![](https://www.diabetesnews.com/wp-content/uploads/2017/10/iStock_000020823647_Small-150x150.jpg)
New research showed that people with type 1 diabetes who used the Diabeloop DBLG1, a “closed-loop” insulin delivery system at home spent a larger percentage of time in their target glucose range, and experienced fewer hypoglycemic events, compared to patients who used an “open-loop” system — their regular pump and sensor. The Diabeloop DBLG1 system consists of a glucose sensor, a patch insulin pump and a smartphone-like device. Read more